SCHEMBL30453312

SCHEMBL30453312

O=Cc1cncc2c1C=CCO2

nearest known ligand 0.36

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.36
CA9 Q16790 1/20 0.36
CYP1A2 P05177 1/20 0.33
CYP1B1 Q16678 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30291346 0.75 CYP2B6 (0.43) CA1CA9CYP1A2CYP1B1
SCHEMBL22114208 0.67
SCHEMBL30389041 0.66 LMNA (0.40)
SCHEMBL28208426 0.64 MEN1 (0.34) CA1CA9CYP1A2CYP1B1
SCHEMBL3411660 0.64 CA1 (0.39) CA1CA9
SCHEMBL31573910 0.62 LMNA (0.41) CA1CA9CYP1A2CYP1B1
SCHEMBL30718710 0.62 ERN1 (0.31)
SCHEMBL27143137 0.62 ERN1 (0.31)
SCHEMBL4049374 0.62 LMNA (0.33)
SCHEMBL435057 0.61 CA1 (0.35) CA1CA9CYP1A2CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023122000-A1 BCL-2 INHIBITORS NEWAVE PHARMACEUTICAL INC. (US) 2023-06-29 WO disclosed